Observational studyFrontiers in endocrinology2023

Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves' orbitopathy: an observational study.

Georgios Boutzios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.